Find policies, billing codes, payers, states, and providers
CPT 41100: Excisional Tongue Biopsy, Anterior Two Thirds
CPT code 41100 designates an excisional biopsy of the anterior two thirds of the tongue, used to obtain diagnostic tissue from lesions or suspicious areas on the tongue. Nationally, this code is relevant to otolaryngology, oral surgery, and head and neck oncology services because timely and accurate tissue diagnosis guides treatment decisions and staging. Payers commonly involved in coverage and reimbursement for this procedure include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of what CPT code 41100 represents, typical clinical settings and service types, and the key considerations for coding and claims in a national context. The publication covers benchmarking items such as usual sites of service and payer mix, summarizes clinical context for when an excisional tongue biopsy is performed, and highlights administrative details that affect billing and documentation. Data not available in the input is noted where applicable, and the content focuses on the code meaning, coverage landscape, and operational context for stakeholders across the health system.
Customize your policy alerts
Sign up for cpt 41100 policy alerts
Get alerted when payer policies referencing 41100 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 41100 describes a surgical procedure in which the clinician makes an incision in the anterior two thirds of the tongue and excises affected tissue for the purpose of biopsy. This is a tongue biopsy with excision intended to obtain diagnostic tissue when lesions or suspicious areas involve the front portion of the tongue.
-
Service type: Surgical biopsy/excisional procedure
-
Typical site of service: Ambulatory surgical center or hospital outpatient department; may also be performed in an office setting with appropriate surgical capabilities